CoChat
Sign Up
Cited by 40Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!

Open access
Ritzwoller, Debra P, Sukhanova, Anna S, Glasgow, Russell E, Strycker, Lisa A, King, Diane K, Gaglio, Bridget, Toobert, Deborah J·2011·Translational Behavioral Medicine
DOI 10.1007/s13142-011-0037-zPMC PMC3212399
Open this paper in CoChat — free account

Abstract

Information on cost-effectiveness of multiple-risk-factor lifestyle interventions for Latinas with diabetes is lacking. The aim of this paper is to evaluate costs and cost-effectiveness for ¡Viva Bien!, a randomized trial targeting Latinas with type 2 diabetes. We estimated 6-month costs; calculated incremental costs per behavioral, biologic, and quality-of-life change; and performed sensitivity analyses from health plan and participant perspectives. Recruitment, intervention, and participant costs were estimated at $45,896, $432,433, and $179,697, respectively. This translates to $4,634 in intervention costs per ¡Viva Bien! participant; $7,723 in both per unit reduction in hemoglobin A1c and per unit reduction in body mass index. Although costs may be higher than interventions that address one risk factor, potential risks for longer-term health-care costs are high for this at-risk group. Given the benefits of ¡Viva Bien!, cost reductions are recommended to enhance its efficiency, adoption, and long-term maintenance without diluting its effectiveness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13142-011-0037-z

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The approximately $1,400 cost of a 1.0 percentage point (11 mmol/mol) reduction in HbA1C in T1-REDEEM falls near the lower range of costs reported in these studies, which in 2017 dollars ranged from $605 for the telephone intervention delivered by lay interviewers to $9,539 for the intensive, in-person intervention.

    “The approximately $1,400 cost of a 1.0 percentage point (11 mmol/mol) reduction in HbA1C observed in T1-REDEEM falls near the lower range of costs reported in these studies which, in 2017 dollars, ranged from $605 in the telephone intervention delivered by lay interviewers25 to $9,539 in the intensive, in-person intervention.26”

    From Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial (2019) · cites this paper as [25]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

  • Per participant costs ranged from $219 for a telephone intervention delivered by lay health educators to $5,390 for an intensive intervention that included a residential retreat and 6 months of weekly, 4-hour, in-person meetings.

    “Per participant costs ranged from $219, for a telephone intervention delivered by lay health educators,25 to $5,390, for an intensive intervention that included a residential retreat, and 6 months of weekly, 4-hour, in-person meetings.26”

    From Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial (2019) · cites this paper as [25]

    The Methods (Recruitment and intervention resources) describe weekly four-hour meetings after a retreat, and the Results (Participant costs) report a 2½-day retreat and 23 meetings. The passages retrieved from our copy do not state the cited $5,390 per-participant figure. The $219 telephone-intervention figure is attached to a different citation in the citing sentence, so it is not assessed against this paper. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 46 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [29]Ball S Golhofner A Comparison of a commercial weight loss program to a fitness center Journal of Exercise Physiology 2008 11 Retrieved February 23, 2011 1 12 from http://faculty.css.edu/tboone2/asep/BallJEPonlineJune2008.pdf

Cited by

Sorted by citations

Related

Authors
Ritzwoller, D. P., Sukhanova, A. S., Glasgow, R. E., Strycker, L. A., King, D. K., Gaglio, B., & Toobert, D. J.
Affiliations
  • Kaiser Permanente (US)
  • Oregon Research Institute (US)
Corresponding author
Ritzwoller, Debra P
ORCID
Venue
Translational Behavioral Medicine
Publisher
Oxford University Press (OUP)
Published
2011-04-07
Volume
1
Issue
3
Pages
427-435
ISSN
  • 1613-9860 (ISSN-L)
  • 1869-6716
DOI
10.1007/s13142-011-0037-z
PMC
PMC3212399
OpenAlex
W2063602132
Cited by
40
References
46
Citations by year
2026: 1 · 2025: 1 · 2022: 2 · 2021: 3 · 2020: 8 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 2 · 2013: 2 · 2012: 2
FWCI
5.68
Type
journal article
Language
en
Open access
Locations
  • Translational Behavioral Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL076151)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, Hispanic women, diabetes self-management, lifestyle intervention, cost-effectiveness, intervention costs, HbA1c, body mass index, quality of life, participant perceptions, health disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review